Evidence map›Paper›PMID 24625819›Full record

ReviewCurrent opinion in cardiology2014

Macro advances in microRNAs and myocardial regeneration.

Jun Wang, James F Martin

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Development of a potency assay for CD34Scientific reports · 2023
    Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. The role of microRNAs in cardiac development and regenerative capacity.American journal of physiology. Heart and circulatory physiology · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jun WangaDepartment of Molecular Physiology and Biophysics bProgram in Developmental Biology, Baylor College of Medicine, One Baylor Plaza cTexas Heart Institute, Houston, Texas, USA.
James F Martin
GTx (United States) · US

Funding

Pitx2 in atrial fibrillationR01HL118761 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2014 to 2025
$6.1M
MicroRNAs in cleft lip and palateR01DE023177 · NIDCR · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2013 to 2017
$2.8M
Pitx2 Function in Cardiac DevelopmentR01HL093484 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MARTIN, JAMES F · 2009 to 2012
$1.5M
NHLBI NIH HHS 5R01HL093484-04NHLBI NIH HHS R01 HL093484NHLBI NIH HHS R01 HL118761NIDCR NIH HHS R01 DE023177NIDCR NIH HHS R01 DE 023177-02
6 · The paper itself

Abstract

purpose of reviewMyocardial injury and disease often result in heart failure, a major cause of death worldwide. To achieve myocardial regeneration and foster development of efficient therapeutics for cardiac injury, it is essential to uncover molecular mechanisms that will promote myocardial regeneration. In this review, we examine the latest progress made in elucidation of the roles of small non-coding RNAs called microRNAs (miRs) in myocardial regeneration. RECENT

findingsPromising progress has been made in studying cardiac regeneration. Several miRs, which include miR-590, miR-199a, miR-17-92 cluster, miR-199a-214 cluster, miR-34a, and miR-15 family, have been recently shown to play an essential role in myocardial regeneration by regulating different processes during cardiac repair, including cell death, proliferation, and metabolism. For example, miR-590 promotes cardiac regeneration through activating cardiomyocyte proliferation, whereas miR-34a inhibits cardiac repair through inducing apoptosis. SUMMARY: These recent findings shed new light on our understanding of myocardial regeneration and suggest potential novel therapeutic targets to treat cardiac disease.

Indexed as

Heart DiseasesMicroRNAsMyocytes, CardiacAnimalsCell Physiological PhenomenaGene Expression RegulationGenetic TherapyHumansRegenerationMicroRNAs

Identifiers

PMID24625819
PMCPMC4286387
OpenAlexW2317010044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.